Pyridostigmine Bromide Solution
Product Images NDC 68682-307

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 68682-307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

This is a medication label for Pyridostigmine Bromide, which is an oral solution used for the treatment of myasthenia gravis (a neuromuscular disorder). Each 5 mL of the solution contains 60 mg of the medicine, and the dosage has to be adjusted based on individual needs. The medication has to be stored at room temperature in a light-resistant container and should be kept out of the reach of children. The given NDC number is 6846230705.*

FDA Label Image

Mestinon-01.jpg (Mestinon 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.